The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors

Virology

Volumn 242, Issue 2, 1998, Pages 366-377

  Moser, Maria ^a   Burns, Cara Carthel ^a   Boomer, Sarah ^a   Overbaugh, Julie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CAT; FELINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

ANIMALIA; FELIDAE; FELINE LEUKEMIA VIRUS; FELIS CATUS; MURINAE; RNA VIRUSES;

EID: 0032520531     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.9008     Document Type: Article

References (38)

1. Aronoff R., Linial M. Specificity of retroviral RNA packaging. J. Virol. 65:1991;71-80.
2. Ben-David Y., Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell. 66:1991;831-834.
3. Boomer S., Eiden M., Burns C. C., Overbaugh J. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor interactions. J. Virol. 71:1997;8116-8123.
4. Boomer S., Gasper P., Whalen L. R., Overbaugh J. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A. Virology. 204:1994;805-810.
5. Brojatsch J., Naughton J., Rolls M. M., Zingler K., Young J. A. T. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell. 87:1996;845-855.
6. Burns C., Moser M., Banks J., Alderete J., Overbaugh J. Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line. Virology. 222:1996;14-20.
7. Burns C. C., Poss M. L., Thomas E., Overbaugh J. Mutations within a putative cysteine loop of the transmembrane protein of an attenuated immunodeficiency-inducing feline leukemia virus variant inhibit envelope protein processing. J. Virol. 69:1995;2126-2132.
8. Donahue P. R., Hoover E. A., Beltz G. A., Riedel N., Hirsch V. M., Overbaugh J., Mullins J. I. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62:1988;722-731.
9. Donahue P. R., Quackenbush S. L., Gallo M. V., deNoronha C. M. C., Overbaugh J., Hoover E. A., Mullins J. I. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J. Virol. 65:1991;4461-4469.
10. Eiden M. V., Farrell K. B., Wilson C. A. Substitution of a single amino acid residue is sufficient to allow the human amphotropic murine leukemia virus receptor to also function as a gibbon ape leukemia virus receptor. J. Virol. 70:1996;1080-1085.
11. Fields-Berry S. C., Halliday A. L., Cepko C. L. A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina. Proc. Natl. Acad. Sci. USA. 89:1992;693-697.
12. Ghosh A. K., Mullins J. I. cDNA encoding a functional feline liver/bone/kidney-type alkaline phosphatase. Arch. Biochem. Biophys. 322:1995;240-249.
13. Goff S., Traktman P., Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:1981;239-248.
14. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:1977;59-74.
15. Grant C. K., Ernisse B. J., Jarrett O., Jones F. R. Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions. J. Immunol. 131:1983;3042-3048.
16. Jarrett O., Laird H. M., Hay D. Determinants of the host range of feline leukemia viruses. J. Gen. Virol. 20:1973;169-175.
17. Kristal B. S., Reinhart T. A., Hoover E. A., Mullins J. I. Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins. J. Virol. 67:1993;4142-4153.
18. Lander M. R., Chattopadhyay S. K. AMus dunni. J. Virol. 52:1984;695-698.
19. McAllister R. M., Gardner M. B., Greene A. E., Bradt C., Nichols W. W., Landing B. H. Cultivation in vitro of cells derived from a human osteosarcoma. Cancer. 27:1971;397-402.
20. Miller A. D., Garcia J. V., von S. N., Lynch C. M., Wilson C., Eiden M. V. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:1991;2220-2224.
21. Miller A. D., Rosman G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques. 7:1989;980-982.
22. Miller A. D., Wolgamot G. Murine retroviruses use at least six different receptors for entry intoMus dunni. J. Virol. 71:1997;4531-4535.
23. Miller D. G., Edwards R. H., Miller A. D. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc. Natl. Acad. Sci. USA. 91:1994;78-82.
24. Overbaugh J., Donahue P. R., Quackenbush S. L., Hoover E. A., Mullins J. I. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science. 239:1988;906-910.
25. Poss M. L., Mullins J. I., Hoover E. A. Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus. J. Virol. 63:1989;189-195.
26. Poss M. L., Quackenbush S. L., Mullins J. I., Hoover E. A. Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein. J. Virol. 64:1990;4338-4345.
27. Quackenbush S. L., Donahue P. R., Dean G. A., Myles M. H., Ackley C. D., Cooper M. D., Mullins J. I., Hoover E. A. Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J. Virol. 64:1990;5465-5474.
28. Reinhart T. A., Ghosh A. K., Hoover E. A., Mullins J. I. Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses. J. Virol. 67:1993;5153-5162.
29. Riedel N., Hoover E. A., Dornsife R. E., Mullins J. I. Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc. Natl. Acad. Sci. USA. 85:1988;2758-2762.
30. Riedel N., Hoover E. A., Gasper P. W., Nicolson M. O., Mullins J. I. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J. Virol. 60:1986;242-250.
31. Riggs J. L., McAllister R. M., Lennette E. H. Immunofluorescent studies of RD-114 virus replication in cell culture. J. Gen. Virol. 25:1974;21-29.
32. Rohn J. L., Linenberger M. L., Hoover E. A., Overbaugh J. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors. J. Virol. 68:1994;2458-2467.
33. Rohn, J. L. Moser, M. S. Gwynn, S. R. Baldwin, D. N. Overbaugh, J. Evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant in vivo.
34. Rohn J. L., Overbaugh J. Pathogenic feline retroviruses: Feline leukemia virus and feline immunodeficiency virus. Persistent Viral Infections. 1997;Wiley, New York.
35. Sarma P. S., Log T. Viral interference in Feline Leukemia-Sarcoma complex. Virology. 44:1971;352-358.
36. Sarma P. S., Log T., Jain D., Hill P. R., Huebner R. J. Differential host r ange of viruses of feline leukemia-sarcoma complex. Virology. 64:1975;438-446.
37. Weiss R. Experimental biology and assay of RNA tumor viruses. Weiss R. A., Teich N. M., Varmus H. E., Coffin J. M. RNA Tumor Viruses. 1984;209-260 Cold Spring Harbor Laboratory, Cold Spring Harbor.
38. Wilson C. A., Farrell K. B., Eiden M. V. Comparison of cDNAs encoding the gibbon ape leukaemia virus receptor from susceptible and nonsusceptible murine cells. J. Gen. Virol. 75:1994;1901-1908.